Evidence map›Paper›PMID 25344695›Full record

ArticleTransactions of the Royal Society of Tropical Medicine and Hygiene2014

Development and validation of serological assays for viral hemorrhagic fevers and determination of the prevalence of Rift Valley fever in Borno State, Nigeria.

David Nadeba Bukbuk, Shuetsu Fukushi, Hideki Tani, Tomoki Yoshikawa, Satoshi Taniguchi, Koichiro Iha, Aiko Fukuma, Masayuki Shimojima, Shigeru Morikawa, Masayuki Saijo and 2 more

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Transactions of the Royal Society of Tropical Medicine and Hygiene, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 4 pooled it
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 4 syntheses or guidelines pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Epidemiology of Lassa Fever.Current topics in microbiology and immunology · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Diagnostic Testing for Crimean-Congo Hemorrhagic Fever.Journal of clinical microbiology · 2020
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 3 countries.

David Nadeba BukbukDepartment of Microbiology and Parasitology, Faculty of Veterinary Medicine, University of Maiduguri, Maiduguri, Nigeria.
Shuetsu FukushiDepartment of Virology 1, National Institute of Infectious Diseases, Tokyo, Japan fukushi@nih.go.jp.
Hideki TaniDepartment of Virology 1, National Institute of Infectious Diseases, Tokyo, Japan.
Tomoki YoshikawaDepartment of Virology 1, National Institute of Infectious Diseases, Tokyo, Japan.
Satoshi TaniguchiDepartment of Virology 1, National Institute of Infectious Diseases, Tokyo, Japan.
Koichiro IhaDepartment of Virology 1, National Institute of Infectious Diseases, Tokyo, Japan.
Aiko FukumaDepartment of Virology 1, National Institute of Infectious Diseases, Tokyo, Japan.
Masayuki ShimojimaDepartment of Virology 1, National Institute of Infectious Diseases, Tokyo, Japan.
Shigeru MorikawaDepartment of Veterinary Science, National Institute of Infectious Diseases, Tokyo, Japan.
Masayuki SaijoDepartment of Virology 1, National Institute of Infectious Diseases, Tokyo, Japan.
Francis KasoloDisease Prevention and Control Cluster at the WHO Regional Office for Africa, Congo-Brazzaville.
Saka Saheed BabaDepartment of Microbiology and Parasitology, Faculty of Veterinary Medicine, University of Maiduguri, Maiduguri, Nigeria.
National Institute of Infectious Diseases · JPUniversity of Maiduguri · NGWorld Health Organization Regional Office for Africa · CG

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundRift Valley fever (RVF) is endemic to the tropical regions of eastern and southern Africa. The seroprevalence of RVF was investigated among the human population in Borno State, Nigeria to determine the occurrence of the disease in the study area in comparison with that of Lassa fever and Crimean-Congo Hemorrhagic fever.

methodsRecombinant nucleoprotein (rNP)-based IgG-ELISAs for the detection of serum antibodies against RVF virus (RVFV), Lassa fever virus (LASV), and Crimean-Congo hemorrhagic fever virus (CCHFV) were used to test human sera in Borno State, Nigeria. The presence of neutralizing antibody against the RVFV-glycoprotein-bearing vesicular stomatitis virus pseudotype (RVFVpv) was also determined in the human sera.

resultsOf the 297 serum samples tested, 42 (14.1%) were positive for the presence of RVFV-IgG and 22 (7.4%) and 7 (2.4%) of the serum samples were positive for antibodies against LASV and CCHFV, respectively. There was a positive correlation between the titers of neutralizing antibodies obtained using RVFVpv and those obtained using the conventional neutralization assay with the attenuated RVFV-MP12 strain.

conclusionsThe seroprevalence of RVF was significantly higher than that of LASV and CCHF in Borno State, Nigeria. The RVFVpv-based neutralization assay developed in this study has the potential to replace the traditional assays based on live viruses for the diagnosis and seroepidemiological studies of RVF.

Indexed as

Rift Valley FeverAntibodies, ViralCross-Sectional StudiesEnzyme-Linked Immunosorbent AssayEpidemiological MonitoringHemorrhagic Fevers, ViralHemorrhagic Fever Virus, Crimean-CongoHumansLassa FeverNigeriaRift Valley fever virusSeroepidemiologic StudiesSerologic TestsAntibodies, ViralNigeriaRift Valley feverSeroprevalence

Identifiers

PMID25344695
PMCPMC7107251
OpenAlexW2324087670

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.